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ABSTRACT
Mice heterozygous for homeobox gene Engrailed-1 display progressive loss of mesencephalic 
dopaminergic (mDA) neurons. We report that exogenous Engrailed-1 and Engrailed-2 
(collectively Engrailed) protect mDA neurons from 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP), a mitochondrial complex I toxin used to model PD in animals. 
Engrailed enhances the translation of nuclear-encoded mRNAs for two key complex I 
subunits, Ndufs1 and Ndufs3, and increases complex I activity. Accordingly, in vivo 
protection against MPTP by Engrailed is antagonized by Ndufs1 siRNA. An association 
between Engrailed and complex I is further confirmed by the reduced expression of Ndufs1 
and Ndufs3 in the substantia nigra pars compacta of Engrailed-1 heterozygous mice. 
Engrailed also confers in vivo protection against 6-hydroxydopamine and α-synuclein-A30P. 
Finally, the unilateral infusion of Engrailed into the midbrain increases striatal dopamine 
content resulting in contralateral amphetamine-induced turning. Therefore, Engrailed is both a 
survival factor for adult mDA neurons and a regulator of their physiological activity. 
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INTRODUCTION 
A key feature of Parkinson disease is the progressive demise of mesencephalic dopaminergic 
(mDA) neurons in the substantia nigra pars compacta (SNpc). The molecular mechanisms 
leading to mDA cell loss are not entirely elucidated. However, several studies indicate that 
mitochondrial complex I impairment plays a central role in this pathology 1-3. In recent years, 
several transcription factors involved in mDA cell development have been identified 4. Some 
of them remain expressed throughout life, including homeoproteins Engrailed-1 (En1) and 
Engrailed-2 (En2) 5, but their adult functions are poorly understood. 
We explored the role of En1/En2 (Engrailed) in the survival of adult mDA cells. The 
two proteins are equivalent in the midbrain 6 and mice heterozygous for En1 (En1+/–En2+/+) 
display a gradual loss of mDA neurons in the SNpc and ventral tegmental area (VTA) 7. This 
loss is more severe in the SNpc than in the VTA, a phenotype reminiscent of Parkinson 
disease, and mutant mice show behavioral (including motor) deficits. Importantly, the 
infusion of Engrailed into the SNpc arrests adult mDA neuronal loss in En1+/–En2+/+ mice 7. 
Engrailed, as many other homeoproteins, is internalized by live cells, gaining access to their 
cytoplasm and nucleus 8. 
This study investigated whether exogenously applied Engrailed protein is 
neuroprotective against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and its 
metabolite MPP+ (1-methyl-4-phenylpyridinium), a classical toxin-based Parkinson disease 
model and to better understand the neuroprotection mechanisms. In this context, it is to note 
that Engrailed, although a transcription factor, also regulates mRNA translation 9, 10. This 
regulation, first observed in growth cones, probably engages the mTOR pathway as it is 
accompanied by the phosphorylation of eIF4E and 4E-BP1, two key regulators of protein 
translation 11. Regulating translation may be a property of several homeoproteins since many 
of them, including Engrailed, bind eIF4E 12, 13.  
We thus examined whether Engrailed survival activity involves translational targets. In 
the case of mDA neurons, this hypothesis is supported by the presence of En1 protein in 
dendrites where no transcription takes place 14. This led us to demonstrate that Engrailed 
regulates the translation of Ndufs1 and Ndufs3, two mitochondrial complex I proteins and that 
this regulation participates in mDA neuron protection against cell death induced by complex 
I-specific neurotoxins. This protection by Engrailed was extended to the 6-hydroxydopamine 
(6-OHDA) and α-synuclein-A30P Parkinson disease models 15, 16. In addition we found that 
Engrailed infused in the midbrain of non-lesioned mice enhanced the levels of striatal 
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dopamine (DA) and induced associated motor activity, suggesting a physiological function for 
a homeoprotein transcription factor in the adult brain. 
 
RESULTS 
Engrailed protects mDA neurons against complex I toxins  
As a first in vitro approach to examine if Engrailed protected mDA neurons in experimental 
Parkinson disease models, embryonic ventral midbrain cells were dissociated at E14.5 and 
cultured for three days before the addition of MPP+ (3 µM) for two days, with or without 
Engrailed. Ten days after plating, the number tyrosine hydroxylase-labeled neurons was 2,003 
± 110 in control cultures and MPP+ decreased this number by 85% (86.73 ± 1.75). En1 and 
En2 similarly enhanced mDA cell survival by two-fold (Fig. 1a) with a dose-dependent 
protection and a maximal effect between 0.3 and 3 nM (Fig. 1b). EnSR, an En2 
internalization deficient mutant 9 had no effect on mDA cell survival (Fig. 1a) indicating that 
survival activity requires internalization. The number of NeuN-positive cells (a neuron 
specific nuclear protein) remained unaffected in all conditions (Fig. 1c). MPP+ is selectively 
captured by the dopamine transporter (DAT), explaining the specific loss of mDA neurons. 
We therefore verified that Engrailed does not protect mDA cells by decreasing DAT activity 
(Supplementary Fig. 1). 
Because Engrailed is expressed in a large majority of embryonic midbrain neurons in 
culture, we examined its protective effect against rotenone, a complex I inhibitor not selective 
for mDA neurons 17. Rotenone (50 nM) kills 37.8% ± 5.5% of TH-positive (Fig. 1d) and 
18.0% ± 2.9% (Fig. 1e) of NeuN-positive neurons. Engrailed alone was without effect on the 
number of NeuN- and mDA cells but fully protected the two populations of neurons against 
rotenone (Fig. 1d,e). In contrast, Engrailed was not effective against 3-nitropropionic acid (3-
NP), a complex II toxin. The number of tyrosine hydroxylase- and NeuN-positive cells was 
reduced by 3-NP (by 36.6% ± 1.9% and 28.8% ± 1.9%, respectively) with no protection by 
Engrailed (Fig. 1f,g). Engrailed therefore protects embryonic midbrain neurons against 
complex I but not complex II toxins.  
  
Engrailed enhances the translation of complex I subunits 
Given that internalized Engrailed regulates translation in growth cones 9, 10, we hypothesized 
that local mRNA translation in response to Engrailed internalization may participate in its 
protective effect. In a first approach, adult midbrain synaptoneurosomes (a fraction enriched 
in synaptic terminals) were treated with En1 (15 nM) or vehicle for 1 h at 37°C in the 
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presence of 35S-methionine/cysteine and newly synthesized En1-regulated proteins were 
identified by mass spectrometry.  
Among 26 proteins identified, 16 were localized to mitochondria, including Ndufs1, a 
key subunit of mitochondrial complex I. Most mitochondrial proteins are encoded by nuclear 
genes and translated from mRNAs surrounding the organelle 18. To further investigate 
Engrailed activity on local translation of complex I proteins, complex I was 
immunoprecipitated from Engrailed- or vehicle-treated radiolabeled synaptoneurosomes. Of 7 
protein bands verified by mass spectroscopy, Engrailed increased the synthesis of Ndufs1 
(+43%) and Ndufs3 (+68%) (Fig. 2a,b), two key proteins for complex I turnover and activity 
19 , 20 Immunoprecipitation of complexes II and V revealed no obvious changes after 
Engrailed treatment (Supplementary Fig. 3). Finally, complex I, but not complex IV, activity 
was increased by 20% in Engrailed-treated synaptoneurosomes, an increase reflected at the 
level of mitochondrial metabolism measured by citrate synthase activity (Fig. 2c).   
Accordingly, Engrailed (3 nM for 4 h) increased the levels of Ndufs1 and Ndufs3 (169% ± 
16% and 363% ± 25%, respectively; Fig. 3a,b) in midbrain cultures. The greater change in 
cells compared to synaptoneurosomes could reflect the fact that all midbrain embryonic 
neurons express Engrailed, whereas synaptoneurosomes are heterogeneous. These increases 
were not observed in the presence of anti-Engrailed antibodies indicating that Engrailed is the 
active entity. Ndufs1 and Ndufs3 increases were maintained in the presence of the 
transcription inhibitor actinomycin D (5 µg/ml), and are thus not dependent on transcriptional 
activity (Fig. 3a,b). Interestingly, Engrailed did not alter the levels of CoxIV, a component of 
complex IV of the respiratory chain (Fig. 3c).  
To further verify that Ndufs1 and Ndufs3 are part of an Engrailed-regulated pathway 
we quantified their expression in the SNpc of En1+/–En2+/+ one-year-old mice and their wild-
type littermates. Ndufs1 and Ndufs3 immunoreactivity in mDA neurons were significantly 
decreased in the SNpc of En1+/–En2+/+ mice (25.39% ± 5.76% and 24.05% ± 7.26%, 
respectively, P<0.05; n = 4 animals per group) (Fig. 4a,b). No change of expression was 
observed for CoxIV (Fig. 4b). Ndufs3 expression showed no change in the oculomotor 
nucleus (Fig. 4b), a mesencephalic structure where Engrailed is not expressed. Nor were there 
any changes in the VTA (Supplementary Fig. 4). Finally, double immunofluorescence 
confirmed a 21.26% ± 3.3% (P<0.01, n = 4 En1+/–En2+/+and n = 4 wt littermates) decrease in 
Ndufs3 expression specifically in tyrosine hydroxylase-expressing neurons from En1+/–En2+/+ 
mice (Fig. 4c,d). All in all, these results demonstrate that Engrailed regulates the local 
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translation of important mitochondrial complex I proteins during development and in the 
adult. 
 
Engrailed protects mDA neurons against MPTP in vivo 
C57Bl/6 mice were unilaterally infused dorsal to the SNpc with a 1:1 mixture of En1/En2 (4.5 
µM in the pump) or saline (sham) from days 1 to 14, and MPTP or saline was administrated 
intraperitoneally (i.p.) daily on days 5 to 9 (Fig. 5a). In these conditions, Engrailed diffuses 
into the SNpc and VTA and is internalized by most neurons in the region 7.  
Engrailed or sham infusion had no effect on tyrosine hydroxylase-positive cell number 
in mice treated i.p. with saline. The number of mDA cells in the SNpc of non-infused 
(contralateral) side, sham-infused, and Engrailed-infused sides of mice treated i.p. with saline 
was 5,687 ± 33 (Fig. 5b). In MPTP administered mice the number of tyrosine hydroxylase-
positive neurons decreased by 32% ± 3.1% (P<0.01). Infusion of Engrailed partially protected 
against MPTP since the number of tyrosine hydroxylase-positive cells was decreased by only 
15.6% ± 3.3% (48.7% protection), comparing Engrailed-infused side to the non-infused side 
(same animals) or to both sides of sham-infused animals (P<0.01) (Fig. 5d). The number of 
tyrosine hydroxylase-negative neurons per side ranged from 1,780 ± 194 to 1,970 ± 170 and 
did not differ significantly between the conditions (Nissl staining, Supplementary Fig. 5). 
Therefore, the higher number of tyrosine hydroxylase-positive cells in Engrailed-infused 
tissues reflects cell survival and not an up-regulation of tyrosine hydroxylase expression.  
To test whether Ndufs1 up-regulation is necessary for Engrailed-mediated mDA 
neuron protection, we co-infused a cell permeable, Penetratin-coupled siRNA 21 against 
Ndufs1 together with Engrailed, and administered systemic MPTP. Penetratin is a cell 
penetrating peptide used to transport cargoes into live cells 22. We first determined conditions 
in which down-regulation of Ndufs1 expression by the siRNA is significant but moderate 
enough not to jeopardize cell survival (Supplementary Fig. 6). MPTP decreased the number 
of TH-positive neurons by 36% ± 3.7% (Fig. 5c) and Engrailed (with a control siRNA) 
limited cell death to 27% ± 4.04% (Fig. 5e), a protective effect fully abolished by a siRNA 
directed against Ndufs1 (Fig 5e). These data confirm that Ndufs1 translation is part of the 
Engrailed neuroprotection pathway.   
 
Engrailed increases striatal DA in vivo 
To examine the functional consequences of Engrailed-mediated protection of mDA neurons, 
we measured striatal DA in Engrailed- or sham-infused animals injected i.p. with MPTP or 
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saline. As expected, striatal dopamine levels were decreased in both ipsi- and contralateral 
sides in sham-infused/MPTP-injected animals as compared to sham-infused/saline-injected 
controls, reflecting mDA cell loss (Fig. 6a). In contrast, ipsilateral striatal dopamine content 
in Engrailed-infused mice injected with MPTP remained in the range of that found in sham-
infused/saline-injected controls. Thus, Engrailed protected against MPTP-induced striatal 
dopamine decrease. 
Dopamine levels in the Engrailed-infused side of MPTP-injected animals were higher 
(>100% of control) than expected given a protection of 50% of mDA neurons, suggesting that 
Engrailed not only provided neuroprotection, but also directly enhanced dopamine synthesis. 
To test this hypothesis, dopamine levels were measured in the striatum of Engrailed-infused 
mice injected with saline. While the number of mDA cells in the SNpc did not change (Fig. 
5c), dopamine levels were increased by more than 50% (Fig. 6a).  
This increase in striatal dopamine thus reflects both a higher number of surviving 
mDA neurons (in MPTP-treated animals) and a higher dopamine content per terminal (in 
MPTP- and in saline-injected animals). We thus used dopamine content to further analyze the 
role of complex I in Engrailed activity. MPTP alone reduced striatal dopamine by 80 to 90% 
(Fig. 6b), and Engrailed infused in presence of a control siRNA rescued DA content to 35% 
of control values whereas Ndufs1 siRNA fully antagonized this rescue. This confirmed that 
Engrailed doubles dopamine striatal concentrations (true for a 50% and 80% reduction, 
compare Fig. 6a and 6b), and that this effect depends on Ndufs1 translation.  
 
Unilateral Engrailed infusion alters turning behavior  
Animals treated systemically with MPTP or saline and infused in the midbrain with different 
compounds were analyzed for amphetamine-induced turning behavior at day 20 (see Fig. 5a). 
Mice injected with MPTP and infused with Engrailed and a control siRNA turn significantly 
toward the contralateral side (–5.83 ± 2.09 net turns/min) compared to animals injected i.p. 
with saline and infused with saline (–0.02 ± 0.83 net turns/min, P<0.01) or injected with 
MPTP and infused with saline (–0.23 ± 0.76 net turns/min, P<0.05).  
After MPTP intoxication, Ndufs1 siRNA injected into the SNpc abolishes the 
amphetamine-induced turning observed after Engrailed and control siRNA infusion (0.13 ± 
1.19 net turns/min versus –5.83 ± 2.09 net turns/min) (Fig. 6c). MPTP injected animals 
infused with Ndufs1 siRNA or saline injected animals infused with control siRNA did not 
show preferential turning (–2.37 ± 0.96 net turns/min and –1.04 ± 0.88 net turns/min, 
respectively). Since siRNAs at the concentration used for these experiments have no effect of 
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their own on dopamine levels or turning behavior, we conclude that Engrailed-induced mDA 
survival, dopamine synthesis and turning involve an increase in Ndufs1 expression.  
Given that Engrailed infusion into the SNpc of control animals dramatically increases 
striatal dopamine levels, the effect of Engrailed on turning behavior was tested. As shown in 
Figure 6d, Engrailed-infused mice turned preferentially contralateral to the side of infusion (–
3.79 ± 0.58 net turns/min versus –0.65 ± 0.37 net turns/min for sham-infused mice P<0.001). 
The non-internalized En2SR variant had no effect (not shown), indicating that internalization 
of Engrailed is necessary for its protective and physiological effects. In conclusion, these 
results confirm that Engrailed, in addition to its survival effects, has a physiological function 
in dopaminergic activity.   
   
Engrailed protects mDA neurons in other Parkinson models 
Although MPTP intoxication is a widely used Parkinson disease model 1, we examined 
whether Engrailed protects mDA neurons in two other models. We first used unilateral 
injection of 6-hydroxydopamine (6-OHDA) in the striatum, which provokes a Wallerian-like 
retrograde degeneration of the nigro-striatal dopamine pathway 15 leading to mDA cell death. 
6-OHDA injection is followed 2 weeks later by the death of 60% of the mDA neurons in the 
SNpc but the infusion of Engrailed in the midbrain reduces cell death to less than 20% (Fig. 
7a).  
 The second model is the injection of cell-permeable mutated α-synuclein-A30P in the 
SNpc recently used to generate new rodent Parkinson disease models on a relatively short 
time-scale 16. The in vitro toxicity of α-synuclein-A30P on midbrain neurons in culture was 
fully antagonized by the addition of En1 (not shown). In vivo, the injection of the highly toxic 
α-synuclein-A30P mutant in the SNpc led to a 40% decrease in TH cell number after 2 weeks 
(Fig. 7b). This cell death was fully antagonized by Engrailed infusion in the ventral midbrain 
immediately after α-synuclein-A30P injection (Fig.7b).  
 These observations demonstrate that Engrailed confers neuroprotection to mDA 
neurons in three established Parkinson disease models.     
 
DISCUSSION 
Midbrain dopaminergic cell survival is compromised in mice with one dysfunctional 
Engrailed allele 5, 7 and the local infusion of Engrailed in the midbrain halts mDA cell death 
in En1 heterozygous mice 7. It is noteworthy that despite the absence of Engrailed mutations 
in familial Parkinson disease, a genetic link between Engrailed and the risk for sporadic 
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Parkinson disease has been postulated 23, 24. We now report that exogenously applied 
Engrailed, which enters live cells, increases complex I activity and protects mDA neurons 
against MPP+/MPTP neurotoxicity in vitro and in vivo. This study also establishes a causal 
link between Engrailed-driven protection against MPP+/MPTP and the translation of complex 
I mitochondrial proteins, in particular Ndufs1.  
Local translation is an important physiological response to local cues and stimulation 11, 
25. Of particular relevance to this study is that Engrailed axon guidance activity requires its 
internalization and local protein translation 9, 10. The present work raises the possibility that 
Engrailed locally regulates translation of mRNAs encoding mitochondrial proteins. In fact, 
given the high number of mitochondria present in synapses and growth cones, the finding that 
the translation of mitochondrial mRNAs is regulated locally is not surprising 26. 
Mitochondrial impairment in Parkinson disease is suggested by several observations. 
First, complex I activity is reduced in the brains of patients 3. Second, MPTP in mice or non-
human primates selectively kills mDA neurons through inhibition of complex I 1. Third, 
genetic studies in familial forms of Parkinson implicate mitochondrial dysfunctions since 
mutated nuclear genes encoding PINK1, Parkin, α-synuclein, DJ-1 and LRRK2 all directly or 
indirectly affect mitochondrial physiology 27, 28. This list underscores the importance of this 
organelle, and of complex I activity in Parkinson disease. 
Mammalian mitochondrial complex I is an assembly of 45 subunits, 7 of which are 
encoded by mitochondrial DNA and the remainder by the nuclear genome. Its catalytic core 
comprises 14 nuclear-encoded subunits among which, Ndufs1 and Ndufs3 are key subunits 
for complex I assembly and activity 19, 29, 30. The observation that Ndufs1 and Ndufs3 are 
specifically down-regulated in mDA neurons in the SNpc of En1+/–En2+/+ mice strengthens 
the correlation between the mDA neuron degeneration observed in En1+/–En2+/+ mice 7 and a 
local decrease in Ndufs1 and Ndufs3. Ndufs1 is a particularly attractive Engrailed target since 
its cleavage by caspase-3 is at the origin of mitochondrial changes associated with cell death 
19. In this report, for practical reasons (siRNA design and controlled down-regulation of 
Ndufs1 expression), we focused on siRNA-mediated Ndufs1 manipulation. This does not 
mean that other complex I subunits are not also downstream targets of the Engrailed survival 
pathway. 
Given the importance of mitochondria and complex I activity in Parkinson disease 1, 31, 
protection of mDA neurons by Engrailed through translational regulation of complex I 
proteins suggested that Engrailed may be effective in several Parkinson disease models. This 
is confirmed by the protective activity of Engrailed in the 6-OHDA and α-synuclein models. 
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It is noteworthy that 6-OHDA induces a retrograde degeneration when injected into the 
striatum, a phenomenon taking place in Parkinson disease 32. The injection of toxic α-
synuclein into the SNpc 16 is particularly pertinent since it mimics a mutation found in the 
human and takes advantage of the “prion-like” character of the protein 33. In our hands, the 
injection of the cell-permeable α-synuclein A30P induced the death of 40% of the mDA cells 
in the SNpc after 2 weeks and this toxicity was entirely blocked by Engrailed-1.  
Other transcription factors important for mDA cell development are also expressed in 
adulthood and might contribute to Parkinson disease. For instance, the conditional knockout 
of Nurr1 in the adult leads to a slow and progressive loss of mDA neurons 34. Similarly, Otx2 
may function as a survival factor for mDA neurons in the VTA 35, 36 that are relatively spared 
in En1+/–En2+/+ mice and less dependent on En1 expression. One can imagine using 
exogenous Otx2 to rescue VTA mDA neurons, an approach validated in a mouse model of 
glaucoma 37, 38.  
 Finally, Engrailed infused into the midbrain increases striatal dopamine levels, 
suggesting a physiological function in the regulation of nigrostriatal activity beyond 
neuroprotection. Indeed, the preferential turning towards the side contralateral to its infusion 
reflects this Engrailed-driven enhanced nigrostriatal function. It is of note that similarly to the 
protective activity against MPTP toxicity, this function is abolished when Ndufs1 synthesis is 
inhibited, suggesting that several Engrailed functions in the mDA pathway involve its ability 
to regulate mitochondrial activity. 
The notion that Engrailed is a regulator of mDA physiology in the adult allows one to 
consider homeoproteins from a non-developmental point of view. Given that En1 was 
detected in the dendrites of mDA neurons in vivo 14, we propose that Engrailed in mDA 
dendrites acts to regulate local protein synthesis, in particular that of proteins participating in 
mitochondrial activity, in response to physiological stimulations.  
In addition to Engrailed, other homeoproteins can regulate translation 9, 12, 39 and the 
binding to eIF4E is a characteristic shared by many of them 39. This raises the possibility that 
similar mechanisms involving other homeoproteins and other cell types could be involved in 
disorders associated with mitochondrial dysfunction. To further widen the context, an 
unsuspected role in the regulation of mitochondrial activity has recently been reported for 
other transcription factors that engage different mechanisms. It was shown for instance that 
Stat3, within mitochondria, interacts with complex I and complex II, and regulates 
mitochondrial activity 40. Similarly, MEF2D activates the transcription of ND6, a 
mitochondria-encoded complex I subunit 41.  
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In conclusion, it is tempting to propose that the present findings, beyond their basic 
biological interest, open new therapeutic perspectives. It is in particular noteworthy that, 
would Engrailed be considered as a putative therapeutic protein, it could not only protect 
neurons that otherwise would undergo degeneration but also increase the functional output of 
the remaining neurons.  
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Figure 1 Engrailed protects against complex I, but not against complex II inhibition  
(a) Engrailed protects cultured embryonic midbrain TH-positive neurons against MPP+. En1 
or En2 (3 nM), but not a non-internalized mutant form of En2, EnSR, enhanced by two fold 
the survival of TH-positive cells after MPP+ (3 µM) treatment. Data are expressed as 
percentage of vehicle (mean ± s.e.m.), which corresponds to 2,003 ± 110 TH-positive cells 
per well. *P<0.05; n = 5-10. Under these culture conditions, about 80% of the cells were 
neurons (Supplementary Fig. 2). 
(b) Dose-dependent protection of Engrailed against MPP+ with maximal protective effects 
between 0.3 and 3 nM. Data are expressed as a percentage of MPP+ treatment (mean ± 
s.e.m.). *P<0.05; n = 5-6. 
(c) The total number of cultured neurons (NeuN-positive cells), 277,000 ± 3,450 (set at 100%) 
is not modified by MPP+ and/or Engrailed treatments.  
(d,e) Engrailed fully protects TH-positive and the total neurons (NeuN-positive) against 
rotenone, an unspecific complex I inhibitor. Rotenone treatment (50 nM, days 4-5) led to a 
40% (mean ± s.e.m.) loss of TH-positive cells (d) and 18% loss of NeuN-positive cells (e). 
*P<0.05; n = 5-7. 
(f,g) The addition of complex II inhibitor 3-NP (100 µM) between days 4-6 in vitro leads to a 
36.6% ± 1.9% (mean ± s.e.m.) reduction of TH-positive neurons (f) and to a 28.8% ± 1.9% 
reduction of NeuN-positive neurons (g), without any protective effect of Engrailed. Data are 
expressed as percentage of control, which corresponds to about 2000 TH-positive and 
270,000 NeuN-positive cells per well, respectively. n.s., non-significant; *P<0.001; n = 7-13.  
 
Figure 2 Engrailed increases the translation of specific complex I subunits and complex I 
activity 
(a) Metabolic labeling of midbrain synaptoneurosomes followed by complex I 
immunocapture, SDS-PAGE analysis and mass spectrometry show an up-regulation by En1 
of complex I subunits, including Ndufs1 and Ndufs3.  
(b) Densitometric quantification of complex I subunits specifically identified by mass 
spectrometry and western blotting comparing the intensity of complex I subunit proteins in 
synaptoneurosomes treated with En1 or vehicle (control). 
(c) Engrailed enhances complex I activity. Complex I activity, but not complex IV activity, is 
increased by 20% in Engrailed-treated synaptoneurosomes. Citrate synthase activity, an index 
of metabolic activity, is also increased by Engrailed. Data are expressed as percentage of 
vehicle-treated synsaptoneurosomes (mean ± s.e.m.), which correspond to a NADH oxidation 
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rate of 188.6 ± 4.7 µmol/min/mg protein for complex I, cytochrome c oxidation rate of 375.8 
± 5.3 µmol/min/mg protein for complex IV and acetyl-CoA conversion rate of 1,028.9 ± 13.7 
µmol/min/mg protein for citrate synthase, respectively. n.s., non-significant; *P<0.05; n = 3-
4. 
 
Figure 3 Engrailed enhances Ndufs1 and Ndufs3 levels in primary midbrain neuron cultures 
(a,b) En1 (3 nM) or vehicle (control) was added for 4 h to primary mesencephalic neurons in 
culture (5DIV), and the steady state levels of Ndufs1, Ndufs3 and actin (gel loading control) 
were estimated by western blotting. Densitometric quantification (mean ± s.e.m.) revealed a 
significant increase in both, Ndufs1 (a) and Ndufs3 (b) proteins, upon En1 treatment. This 
increase was completely blocked by preincubation of En1 with an anti-Engrailed antibody 
(Ab 86/8; 7) and was unaffected by an actinomycin D (actD) treatment (5 µg/ml), sufficient to 
block transcription (verified by Q-RT-PCR; data not shown).  
(c) Under the same conditions, the amounts of Cox IV remained unaffected. n.s., non-
significant; *P<0.05; n = 5.  
 
Figure 4 Ndufs1 and Ndufs3 expression levels are decreased in En1+/–En2+/+ mice 
(a) Immunohistochemical analysis of Ndufs1 staining in the SNpc. Free-floating cryosections 
of the entire midbrain of one-year old En1+/–En2+/+ animals and wt littermates were stained 
for Ndufs1 (and Ndufs3, not shown). Neurons of the SNpc of mutant mice show a decrease in 
the amount of the proteins. Scale bars correspond to 100 µm. 
(b) Quantification of Ndufs1, Ndufs3 and Cox IV staining. Optical density per neuron in the 
SNpc was measured, demonstrating a decrease in Ndufs1 (25.39 ± 5.76; mean ± s.e.m.) and 
Ndufs3 (24.05% ± 7.26%) protein. The intensity of Cox IV staining was identical in mutant 
and wt mice. *P<0.05; n = 4 Ndufs3 staining intensity analyzed in the nucleus of the 
oculomotor nerve showed no alteration in En1+/–En2+/+ animals *P<0.05; n = 4. 
(c) Double-fluorescence immunostaining of Ndufs3 and TH on free-floating coronal 
vibratome sections of one-year-old En1+/–En2+/+ mice and wt littermates (confocal sections). 
(d) Ndufs3 staining intensity was decreased by 21.26% ± 3.3% (mean ± s.e.m.) in TH-
positive neurons compared to wt animals. *P<0.01; n = 3. 
 
Figure 5 Engrailed protection against MPTP is Ndufs1-dependent 
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(a) Experimental scheme. C57Bl/6 mice were infused with a mixture of En1/En2 (1:1, 4.5 µM 
total) for 14 days dorsal to the SNpc. MPTP (30 mg/kg) or saline was injected (i.p.) for 5 
consecutive days starting on day 5 after pump implantation, 42 and killed on day 21. 
(b) Compared to the sham-infused side, the Engrailed-infused side of MPTP-injected animals 
shows a partial preservation of TH-positive neurons in the SNpc (peroxydase 
immunostaining). Scale bar, 100 µm.  
(c) Representative images of the ipsilateral (Engrailed plus siRNA infused side) and the 
contralateral (non-infused) side of the same animal.   
(d) The non-infused side of control mice injected with saline was set at 100% of TH-positive 
cells and used for comparison with all other conditions. MPTP decreased the number of TH-
positive cells by 32.1% ± 3.1% (mean ± s.e.m.) on sham-infused and contralateral side 
(*P<0.01). The infusion of En1/En2 reduced cell loss to 15% ± 3.4% (#P<0.01). Data are 
expressed as percentage of control, n = 6-10 animals/group. c, contralateral, non-infused side; 
S, sham-infused side; En, Engrailed-infused side. The number of TH negative neurons 
remained constant in all conditions (Supplementary Fig. 5). 
(e) The number of TH-positive neurons in the MPTP-treated animals (3964 ± 300.2) is 
decreased by 36% ± 3.7%. Engrailed protection against MPTP (+26.1%) was abolished by the 
Ndufs1 siRNA (4065 ± 414.1) but not by a control siRNA (4556 ± 251.8). Data are expressed 
as percentage of control. *P<0.05; n = 4-7. c, contralateral. 
 
Figure 6 Engrailed-driven increases in striatal DA and turning behavior after MPTP are 
Ndufs1-dependent  
 (a) MPTP induces a 46% ± 2.3% (mean ± s.e.m.) decrease in striatal DA content compared to 
non-lesioned animals. Engrailed infusion fully antagonizes this decrease (115.25% ± 
19.23%). Saline-injected control mice infused with Engrailed show a 77.5% ± 20.42% 
increase in striatal dopamine compared to baseline levels (saline-infused mice and the non-
infused contralateral side of the same animals). c, contralateral side; S, sham-infused; En, 
Engrailed-infused. *P<0.05; #P<0.05; n = 4-8. 
(b) In conditions where MPTP decreased DA 90%, Engrailed infusion enhanced DA 
concentration by 3.5 fold (35% of saline-injected, sham-infused controls). Protection was 
fully blocked by the Ndufs1 siRNA but not by a control siRNA (saline-injected, sham-infused 
controls set as 100%, n = 5-7). c, contralateral side; S, sham-infused; En, Engrailed-infused.  
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(c) Engrailed induces significant contralateral turning in MPTP intoxicated animals in the 
presence of a control siRNA. This behavior is fully antagonized when Engrailed is co-infused 
with Ndufs1 siRNA. Data expressed in net turns/min. *P<0.05, **P<0.01; n = 5-10. 
(d) Engrailed significantly induces amphetamine-induced contralateral turning in non-
lesioned animals compared to sham-infused animals. ***P<0.001; n  = 17. 
 
Figure 7 Engrailed protects against 6-OHDA and α-synuclein A30P toxicity 
(a) 6-OHDA decreased the number of TH-positive neurons by 59.35 % ± 2.54 % (mean ± 
s.e.m.) (*P<0.001) compared to the non-treated side of each animal. The infusion of En1/En2 
reduced cell loss to 17.81% ± 6.12% (#P<0.001). Data are expressed as percentage of control, 
n = 6-10 animals/group. S, sham-infused animals; En, Engrailed-infused animals.  
(b) Treatment with A30P α-synuclein decreased the number of TH-positive neurons by 
33.47% ± 9.93% s (*P=0.005) compared to the non-treated side and infused En fully 
protected (compared to saline, #P<0.001). No difference was detectable between the α-
synuclein A30P/En and control groups (P=0.46). Data are expressed in percentage of control, 
n = 4-6 animals/group. S, sham-infused animals; En, Engrailed-infused animals.  
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ONLINE METHODS 
 
Animal treatments. Animals were treated in accordance with the guide for the care and use 
of laboratory animals (National Institutes of Health, Bethesda, MD) and the European 
Directive N°86/609. Nine week-old male C57BL/6J mice (Janvier, France) were infused with 
Engrailed as described 7. Briefly, En1/En2 recombinant proteins produced in bacteria were 
dialyzed against 0.9% NaCl, and osmotic mini pumps (Alzet model 1002, Charles River 
Laboratories, France) were filled with 75 µg/ml of each protein (4.5 µM total Engrailed) and 
1.5 µg/µl colominic acid in saline. Mice were infused for 14 days into a region dorsal to the 
SNpc (a/p: –3.3 mm; m/l: –1 mm; d/v: –3 mm relative to bregma) according to the atlas of 
Franklin and Paxinos 42, with a solution containing En1/En2/colominic acid or vehicle, 
respectively. For the siRNA experiments, 1 µM of Penetratin-coupled siRNA against Ndufs1 
or a control siRNA were added to the respective minipump solution containing 
En1/En2/colominic acid or vehicle 20. Five days after pump implantation, mice received 
MPTP-HCl (Sigma–Aldrich) at a concentration of 30 mg/kg once a day (i.p.) or equal 
volumes of saline for 5 consecutive days (‘subchronic paradigm’; 41). For TH-positive cell 
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counting and HPLC, mice were sacrificed on day 21, one week after termination of Engrailed 
delivery. Intrastriatal 6-OHDA injection (4 µg in 2 µl) was performed as described 15 at the 
same session when pumps with Engrailed or vehicle were implanted in the midbrain. Animals 
were sacrificed 14 days after treatment. The penetratin coupled α-synuclein A30P protein (4 
µg) was injected in the SNpc followed by pump implantation to infuse Engrailed or vehicle. 
Animals were sacrificed 2 weeks after treatment. 
 
Cell cultures. Primary mesencephalic cultures of E14.5 rat and mouse embryos were 
prepared as reported 43, 44. For MPP+, rotenone and 3-NP experiments, cells were plated into 
well coated with polyethylenimine and cultured in N5 medium 44 supplemented with 5% 
horse serum, and 0.5% FCS, except for the first 3 days when 2.5% FCS was added to 
facilitate cell attachment. Cells were treated with 2 µM AraC (Sigma-Aldrich) to block 
astrocyte growth and 2 µM MK801 (Sigma-Aldrich) to prevent excitotoxic cell damage. 
Toxins were added between days 4 and 6 at a concentration of 3 µM (MPP+), 100 µM (3-NP) 
and 50 nM (rotenone, only day 4 to day 5). The total number of TH-positive neurons in 
controls was about 0.7% of all neurons as previously described 45. For all other experiments, 
cells were cultured in Neurobasal medium (Gibco) supplemented with 500 µM glutamine, 25 
µM glutamate and 25 µM aspartate and B27 (Gibco) in wells coated with poly-L-ornithine 
and laminine (Sigma). After 5 days, cells were treated as indicated and subjected to Western 
blot analysis as indicated below. Where indicated, actinomycin D was used at 5 µg/ml and 
En1 was preincubated with 67-fold molar excess of an anti-Engrailed antibody (86/8,7) for 1 
hour.  
 
Immunohisto/cytochemistry. Immunohistochemistry (IHC) was performed on free-floating 
cryosections (20 µm) encompassing the entire midbrain of paraformaldehyde-fixed brains 46. 
For Ndufs1, Ndufs3 and Cox IV, sections were incubated for 30 min at 100°C in 100 mM 
Tris-HCl pH 9.5 and 5% urea prior to stainings. The primary antibodies for IHC and 
immunocytochemistry (ICC) with cultured cells were: anti-TH rabbit polyclonal antibody 
(Pel-Freez Biologicals), anti-Engrailed rabbit polyclonal antibody 86/8 (produced in house), 
anti-Ndufs3 mouse monoclonal (Abcam), anti-Ndufs1 mouse polyclonal (Abcam); anti-NeuN 
(neuronal nuclei) streptavidin conjugated mouse polyclonal antibody (Chemicon) and anti-
Cox IV rabbit polyclonal antibody (Cell Signaling). For IHC, the secondary antibodies used 
were: anti-rabbit-HRP (Vector Lab), anti-mouse-HRP (Vector Lab). Staining was revealed 
with chromogen diaminobenzidine (DAB). For ICC, the secondary antibodies used were: 
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donkey anti-mouse conjugated with Cy3 (Sigma), goat anti-rabbit conjugated with Alexa 488 
(Invitrogen), Biotin-conjugated Cy3 or Cy5 and goat anti-mouse conjugated with Alexa 488 
(Invitrogen).  
 
Quantification of in vitro neuron survival. Survival of mDA neurons was quantified by 
counting the number of TH positive neurons. All neurons regardless of their neurotransmitter 
phenotype were identified by NeuN immunofluorescence staining. 
 
Cell counting. TH-positive neurons were visualized in bright field (Nikon Optiphot-2) and 
quantified stereologically on regularly spaced sections covering the mesencephalon from the 
rostral pole of the SNpc to the locus coeruleus (Mercator T4.18 stereology software) 17. The 
SNpc was identified according to established anatomical landmarks 42. Cell loss was verified 
by Nissl counterstaining. 
 
Quantification of Ndufs1 and Ndufs3 staining in the SNpc of En1+/–En2+/+ mice. IHC-
DAB staining for Ndufs1 and Ndufs3 was performed as above using free-floating 
cryosections (20 µm) of the entire midbrain of one year old En1+/-En2+/+ mice and wt 
littermates (4 mice for each group). The quantification of optical density was done using 
Mercator T4.18 software (ExploraNova, La Rochelle, France). For each section, background 
was adjusted. Cells (40-60 per side) were chosen randomly and optical density was measured 
at 20x magnification over the surface of single neurons. Ndufs3 staining in the control region 
(oculomotor nucleus) was analyzed accordingly on the same slices. 
The quantification of Ndufs3 in mDA neurons in SNpc was also performed by 
immunofluorescence using free floating coronal vibratome sections (70 µm) of one year old 
En1+/–En2+/+ mice and wt littermates (n = 3).  Briefly, after antigen retrieval, sections were 
permeabilized, blocked, incubated in mouse anti-Ndufs3 and rabbit anti-TH and then in goat 
anti-mouse and goat anti-rabbit antibodies conjugated respectively to Alexa Fluor 488 and 
555. Images were recorded on a Leica TCS SP2 confocal microscope (Leica Microsystems) 
equipped with a 40x oil-immersion objective (NA=1.00). Gains were adjusted to avoid 
saturation in pixels intensity. Two brain sections within the same region of the SNpc and 
spaced apart by 140 µm were selected for each animal (3 mice par group). In each section, 4 
to 6 fields covering the whole SNpc were then acquired with constant imaging parameters at a 
depth of 10 to 20 µm below the coverslip. Altogether a total of 29 and 33 fields were acquired 
for wt and En1+/–En2+/+ mice, respectively. The quantitative analysis was performed in Image 
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J. TH images were first smoothed and thresholded to yield a binary image which was then 
used as a mask to measure Ndufs3 staining intensity only in TH-positive structures (mDA 
neurons). Ndufs3 staining intensity was also quantified in TH-positive neurons in the VTA of 
wt and En1+/–En2+/+ on the same sections (Supplementary Fig. 4). 
 
Metabolic labeling of synaptoneurosomes and complex I, II and V immunocapture. 
Synaptoneurosomes prepared from ventral midbrains of 4 week-old C57BL/6 mice by 
filtration 47 48 were incubated for 1 h at 37°C with [35S]methionine/[35S]cysteine (Promix; 
Amersham) and either Engrailed or vehicle and subjected to 2-D SDS-PAGE and 
autoradiography. Newly translated proteins were identified by liquid chromatography 
electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS). For the immunocapture 
of complex I, II and V, mitochondria were isolated from synaptoneurosomes and 
immunoprecipitations of complex I, II and V were performed following the manufacturer’s 
protocol (MitoProfile complex I, II and V Immunocapture Kit, MitoScience). The materiel 
was analyzed by SDS-PAGE and bands corresponding to subunits of the respective 
complexes were visualized by phosphorimager. In the case of complex I, proteins 
corresponding to visible bands were identified by LC-ESI-MS/MS. For complex II and V, 
protein bands were identified according to the respective molecular weights as known from 
the literature. Quantification of complex I subunits was done using ImageJ. Background was 
substracted and the densitometric value of engrailed-treated samples compared to control 
determined.    
  
Mitochondrial activity. Complex I, complex IV and citrate synthase activities were 
measured as described 17. In brief, extracts prepared from synaptoneurosomes treated or not 
with En1 (15 nM) for 1 h at 37°C, were mixed with 10 mM Tris–HCl pH 7.2, 225 mM 
mannitol, 75 mM saccharose and 0.1 mM EDTA. Complex I and IV activities were analyzed 
spectophotometrically by measuring the rate of NADH (complex I) and cytochrome c 
(complex IV) oxidation during 3 min at 37°C in an assay mixture containing 40 µg protein of 
synaptoneurosomal extracts. Complex I activity was measured in the absence and the 
presence of 2 µM rotenone, and the rotenone-sensitive activity was attributed to complex I. 
Citrate synthase activity was measured spectophotometrically using Acetyl-CoA and 
oxaloacetate during 0.8 min at 37°C. 
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siRNA coupling to Penetratin and testing in vivo. A predesigned siRNA against Ndufs1 
(Target sequence: 5’-ATGCATGAAGATATTAATGAA-3’; Qiagen) or control siRNA with 
a Thio-C6-linker modification on the 5’ end of the sense strand was incubated with an 
equimolar quantity of Tris(2-carboxyethyl)phosphine hydrochloride (Sigma) before addition 
of activated Penetratin 1 (Q-Biogene) in two-fold molar excess and the mix was heated at 
65°C and further incubated at 37°C before aliquoting and freezing. For in vivo testing, a 1 μM 
solution of Penetratin-coupled Ndufs1 siRNA or control siRNA was infused in 8-week-old 
C57BL/6 mice as described above using 3-day micro-osmotic pumps. The ventral midbrain 
encompassing the SNpc was dissected 3 days after pump implantation and processed for 
western blot analysis. This resulted in moderate but significant Ndufs1 downregulation 
(Supplementary Fig. 6).  
 
Western blot analysis. Western blot analyses were performed using standard procedures with 
the following primary antibodies: anti-Ndufs1 rabbit polyclonal (Proteintech), anti-Ndufs3 
mouse monoclonal (Abcam), anti-COX IV rabbit polyclonal (Cell Signaling) and anti-actin 
goat polyclonal (Santa Cruz). The bands were quantified by densitometry. 
 
HPLC. For DA measurements, striatal extracts were prepared and analyzed by HPLC using a 
reverse phase column (Nucleosil 120-3 C18; Knauer, Berlin, Germany) and electrochemical 
detection as described 15. Data were recorded and quantified using HPLC Chromeleon 
computer system (Dionex, Germany). 
 
Turning behavior. Amphetamine-induced rotation behavior was measured as previously 
described 49. Mice received 5 mg/kg D-amphetamine hemisulfate salt (Sigma-Aldrich) and 
were placed after 20 min into individual glass bowls. Contralateral and ipsilateral turning 
were recorded for 5 min. Results are expressed as net turns/min. Significant contralateral 
turning indicates an increase in nigrostriatal dopaminergic activity on the infused ipsilateral 
side 49.  
 
Quantification of DAT activity. DAT activity was determined in cultured cells treated or not 
with Engrailed by measuring [3H]-dopamine uptake as described 45. Engrailed treatment did 
not alter DAT activity (Supplementary Fig. 1).  
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Statistical analysis. Data are expressed as mean ± standard error of the mean (s.e.m) if not 
otherwise indicated. All in vitro experiments were performed at least in triplicate. 
Experimental data were compared by one-way ANOVA and a post-hoc Student-Newman-
Keuls test for pair-wise comparisons and post-hoc Dunnett’s test when compared to controls. 
P<0.05 was considered significant. 
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Supplementary Fig. 1 Engrailed treatment has no effect on DAT activity.  
DAT-activity was measured by the uptake of [3H]-dopamine in mesencephalic cultures 
treated or not with Engrailed (3 nM). The cultures were preincubated for 10 min with 500 µl 
PBS, 5 µM glucose and 100 µM ascorbic acid prior to the addition of 50 nM [3H]-dopamine 
(30 mCi/mmol). The incubation was stopped after 15 min by two rapid washes with cold 
PBS. The cells were scraped off and radioactivity was measured in a liquid scintillation 
spectrophotometer. Blank values, determined with 5 µM of the dopamine uptake inhibitor 
GBR-12909, represented less than 10% of total uptake in control conditions. Data are 
expressed in percentage of control values, which corresponds to 24,400 cpm. 
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Supplementary Fig. 2 Quantification of neurons and astrocytes in mesencephalic cultures  
Neuronal cultures were fixed after 5 days in vitro and stained with Tuj1, a neuronal marker, 
and S100 beta, a glial marker. Scale bar, 100 µm. The graph depicts the percentage of each 
cell type.  
 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Fig. 3 Engrailed does not affect the synthesis of complex II or complex V 
subunits  
Metabolic labeling of midbrain synaptoneurosomes followed by complex II and complex V 
immunocapture and SDS-PAGE does not reveal any change upon Engrailed treatment.  
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Supplementary Fig. 4 Ndufs3 expression in mDA neurons in the VTA of wt and En1+/- mice 
Ndufs3 levels in TH positive neurons in the VTA area were quantified as for mDA neurons in 
the SNpc area using the same sections as described in the legend of Fig. 4. The values for wt 
and En1+/- mice are not significantly different.  
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Supplementary Fig. 5 The number of TH-negative neurons remains constant upon MPTP 
treatment 
The non-infused side of control mice injected with saline was set as 100% of TH-negative, 
Nissl-positive cells and used for comparison with all other conditions. As expected MPTP did 
not affect the number of TH-negative neurons indicating that differences seen in TH-positive 
neurons are true cell loss and not to a reduction in TH immunostaining. No conditions showed 
a significant difference compared to controls. Data are expressed in percentage of control, n = 
6-10 animals/group. c, contralateral, non-infused side; S, sham-infused side; En, Engrailed-
infused side.  
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Supplementary Fig. 6 Verification of siRNA used against Ndufs1 
(a) Western blot analysis of siRNA infused ventral midbrain extracts. Penetratin-coupled 
siRNA against Ndufs1 or control siRNA were infused for three days with a minipump into a 
region dorsal to the substantia nigra. The Western blots shows decreased amounts of Ndufs1 
as compared to a control siRNA. (b) Quantification of Western blot analysis. The average 
ipsilateral versus contralateral ratio of Ndufs1 levels normalized to actin was calculated for 
each condition. Ndufs1 siRNA decreased Ndufs1 protein level on the infused side as 
compared to the contralateral side by about 30%. * P<0.05 (n = 3-4). 
 
 
 
 
 
 
 
